| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 7.483 | 64.402 | 97.525 | 113.075 | 113.001 | 74.071 |
| Total Income - EUR | - | - | - | 0 | 7.483 | 73.873 | 113.307 | 117.501 | 116.600 | 86.710 |
| Total Expenses - EUR | - | - | - | 82 | 20.063 | 34.220 | 83.748 | 111.356 | 101.650 | 122.297 |
| Gross Profit/Loss - EUR | - | - | - | -82 | -12.580 | 39.654 | 29.559 | 6.145 | 14.950 | -35.587 |
| Net Profit/Loss - EUR | - | - | - | -82 | -12.670 | 39.039 | 28.668 | 5.182 | 13.876 | -37.163 |
| Employees | - | - | - | 0 | 2 | 4 | 4 | 2 | 1 | 2 |
Check the financial reports for the company - Adedent Sam Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 32.690 | 27.041 | 52.054 | 102.915 | 94.816 | 69.090 |
| Current Assets | - | - | - | 69 | 1.694 | 38.925 | 55.433 | 58.904 | 87.087 | 70.521 |
| Inventories | - | - | - | 0 | 0 | 0 | 2.814 | 2.701 | 0 | 0 |
| Receivables | - | - | - | 0 | 271 | 269 | 40.306 | 32.957 | 37.249 | 41.811 |
| Cash | - | - | - | 69 | 1.424 | 38.657 | 12.313 | 23.246 | 49.837 | 28.710 |
| Shareholders Funds | - | - | - | -39 | -12.708 | 26.573 | 28.708 | 5.223 | 13.925 | -37.114 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 107 | 47.092 | 2.636 | 48.940 | 139.450 | 154.482 | 166.884 |
| Income in Advance | - | - | - | 0 | 0 | 36.758 | 29.840 | 17.147 | 13.496 | 9.842 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Adedent Sam Laboratory S.r.l.